Stoke Therapeutics (STOK) Announces CEO Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Stoke Therapeutics Announces CEO Transition
March 18, 2025 6:58 AM EDTEdward M. Kaye, M.D., to Step Down as Chief Executive Officer
Director Ian F. Smith Appointed Interim Chief Executive Officer
Arthur Tzianabos Appointed Interim Executive Chairman of the Board
Board of Directors Initiates Search for Permanent Chief Executive Officer
BEDFORD, Mass.--(BUSINESS WIRE)--... More
